| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |